Skip to main content
Top
Published in: Current Rheumatology Reports 6/2012

01-12-2012 | VASCULITIS (LR ESPINOZA, SECTION EDITOR)

Cocaine-Induced Vasculitis: Clinical and Immunological Spectrum

Authors: Luis R. Espinoza, Rodolfo Perez Alamino

Published in: Current Rheumatology Reports | Issue 6/2012

Login to get access

Abstract

Levamisole-contaminated cocaine has recently been recognized in North America and Europe, and its use is associated with a variety of clinical and autoimmune abnormalities. The clinical characteristic seems to be the presence of a painful purpuric skin rash that predominantly affects the ear lobes and cheeks, often accompanied by systemic manifestations including fever, malaise, arthralgias, myalgias, and laboratory abnormalities, for example leukopenia, neutropenia, positive ANA, ANCA, and phospholipid antibodies. Most of these manifestations can be seen with the use of either drug, especially levamisole. There is no specific therapy, and discontinuation of its use is followed by improvement. Prednisone and immunosuppressive therapy may be needed at times. Further use of the drug is characterized by recurrence of most of the complaints.
Literature
1.
go back to reference Di Paolo T, Rouillard C, Morissette M, Levesque D, Bedard PJ. Endocrine and neurochemical actions of cocaine. Can J Physiol Pharmacol. 1989;67:1177–81.PubMedCrossRef Di Paolo T, Rouillard C, Morissette M, Levesque D, Bedard PJ. Endocrine and neurochemical actions of cocaine. Can J Physiol Pharmacol. 1989;67:1177–81.PubMedCrossRef
2.
go back to reference Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369:1047–53.PubMedCrossRef Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007;369:1047–53.PubMedCrossRef
3.
go back to reference Seyer BA, Grist W, Muller S. Aggressive destructive midfacial lesion from cocaine abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:465–70.PubMedCrossRef Seyer BA, Grist W, Muller S. Aggressive destructive midfacial lesion from cocaine abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:465–70.PubMedCrossRef
4.
go back to reference • Stahelin L, Fialho SC, Neves FS, Junckes L, de Castro GR W, Pereira IA. Cocaine-induced midline destruction lesions with positive ANCA test mimicking Wegener’s granulomatosis. Rev Bras Reumatol. 2012;52:434–7. Interesting case report and literature review about cocaine-induced midline lesions mimicking Wegener’s granulomatosis.CrossRef • Stahelin L, Fialho SC, Neves FS, Junckes L, de Castro GR W, Pereira IA. Cocaine-induced midline destruction lesions with positive ANCA test mimicking Wegener’s granulomatosis. Rev Bras Reumatol. 2012;52:434–7. Interesting case report and literature review about cocaine-induced midline lesions mimicking Wegener’s granulomatosis.CrossRef
5.
go back to reference Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004;50:2954–65.PubMedCrossRef Wiesner O, Russell KA, Lee AS, Jenne DE, Trimarchi M, Gregorini G, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004;50:2954–65.PubMedCrossRef
6.
go back to reference Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008;59:483–7.PubMedCrossRef Brewer JD, Meves A, Bostwick JM, Hamacher KL, Pittelkow MR. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008;59:483–7.PubMedCrossRef
7.
go back to reference Hofbauer GF, Burg G, Nestle FO. Cocaine-related Stevens–Johnson syndrome. Dermatology. 2000;201:258–60.PubMedCrossRef Hofbauer GF, Burg G, Nestle FO. Cocaine-related Stevens–Johnson syndrome. Dermatology. 2000;201:258–60.PubMedCrossRef
8.
go back to reference Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med. 1989;87:664–8.PubMedCrossRef Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med. 1989;87:664–8.PubMedCrossRef
9.
go back to reference Wijnen PA, Bekers O, Drent M. Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers. Mol Diagn Ther. 2011;15:177–80.PubMedCrossRef Wijnen PA, Bekers O, Drent M. Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers. Mol Diagn Ther. 2011;15:177–80.PubMedCrossRef
10.
go back to reference Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177–96.PubMed Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9:177–96.PubMed
11.
go back to reference Nzerue CM, Hewan-Lowe K, Riley Jr LJ. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am J Kidney Dis. 2000;35:783–95.PubMedCrossRef Nzerue CM, Hewan-Lowe K, Riley Jr LJ. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am J Kidney Dis. 2000;35:783–95.PubMedCrossRef
12.
go back to reference Sirvent AE, Enriquez R, Andrada E, Amoros F, Gallego JA, Gonzalez C, et al. Goodpasture’s syndrome in a patient using cocaine—a case report and review of the literature. Clin Nephrol. 2007;68:182–5.PubMed Sirvent AE, Enriquez R, Andrada E, Amoros F, Gallego JA, Gonzalez C, et al. Goodpasture’s syndrome in a patient using cocaine—a case report and review of the literature. Clin Nephrol. 2007;68:182–5.PubMed
13.
go back to reference Fabbian F, Pala M, De Giorgi A, et al. Left kidney: an unusual site of cocaine-related renal infarction. A case report. Eur Rev Med Pharmacol Sci. 2012;16:30–3.PubMed Fabbian F, Pala M, De Giorgi A, et al. Left kidney: an unusual site of cocaine-related renal infarction. A case report. Eur Rev Med Pharmacol Sci. 2012;16:30–3.PubMed
15.
go back to reference Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum. 1995;25:172–83.PubMedCrossRef Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum. 1995;25:172–83.PubMedCrossRef
16.
go back to reference Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46:1291–6.PubMedCrossRef Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46:1291–6.PubMedCrossRef
17.
go back to reference Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996;46:1741–3.PubMedCrossRef Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology. 1996;46:1741–3.PubMedCrossRef
18.
go back to reference Su J, Li J, Li W, Altura BT, Altura BM. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage. Eur J Pharmacol. 2003;482:61–6.PubMedCrossRef Su J, Li J, Li W, Altura BT, Altura BM. Cocaine induces apoptosis in cerebral vascular muscle cells: potential roles in strokes and brain damage. Eur J Pharmacol. 2003;482:61–6.PubMedCrossRef
19.
go back to reference Han JS, Mandell DM, Poublanc J, Mardimae A, et al. BOLD-MRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol. 2008;4:628–32.PubMedCrossRef Han JS, Mandell DM, Poublanc J, Mardimae A, et al. BOLD-MRI cerebrovascular reactivity findings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol. 2008;4:628–32.PubMedCrossRef
20.
go back to reference Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20:443–9.PubMedCrossRef Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20:443–9.PubMedCrossRef
21.
go back to reference Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology. 2011;32:410–2.PubMedCrossRef Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology. 2011;32:410–2.PubMedCrossRef
22.
go back to reference Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg–Strauss vasculitis. Eur Respir J. 1996;9:175–7.PubMedCrossRef Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg–Strauss vasculitis. Eur Respir J. 1996;9:175–7.PubMedCrossRef
23.
go back to reference Chen SC, Jang MY, Wang CS, Tsai KB, et al. Cocaine-related vasculitis causing scrotal gangrene. Ann Pharmacother. 2009;43:375–8.PubMed Chen SC, Jang MY, Wang CS, Tsai KB, et al. Cocaine-related vasculitis causing scrotal gangrene. Ann Pharmacother. 2009;43:375–8.PubMed
24.
go back to reference •• Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use—four States, March 2008–November 2009. MMWR Morb Mortal Wkly Rep. 2009;18:1381–5. Initial report describing agranulocytosis associated with levamisole-contaminated cocaine use. •• Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use—four States, March 2008–November 2009. MMWR Morb Mortal Wkly Rep. 2009;18:1381–5. Initial report describing agranulocytosis associated with levamisole-contaminated cocaine use.
25.
go back to reference Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133:466–72.PubMedCrossRef Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol. 2010;133:466–72.PubMedCrossRef
26.
go back to reference Ejlertsen B, Mouridsen HT, Jensen MB, et al. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer. Cancer. 2010;116:2081–9.PubMed Ejlertsen B, Mouridsen HT, Jensen MB, et al. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer. Cancer. 2010;116:2081–9.PubMed
27.
go back to reference Oh J, Kemper MJ. Second-line options for refractory steroid-sensitive and –resistant nephritic syndrome. Expert Rev Clin Pharmacol. 2010;3:527–37.PubMedCrossRef Oh J, Kemper MJ. Second-line options for refractory steroid-sensitive and –resistant nephritic syndrome. Expert Rev Clin Pharmacol. 2010;3:527–37.PubMedCrossRef
28.
go back to reference Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography–tandem mass spectrometry. J Anal Toxicol. 2011;35:176–8.PubMedCrossRef Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography–tandem mass spectrometry. J Anal Toxicol. 2011;35:176–8.PubMedCrossRef
29.
go back to reference Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978;18:407–8.CrossRef Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J. 1978;18:407–8.CrossRef
30.
go back to reference Symoens J, Veys E, Mielans M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep. 1978;62:1721–30.PubMed Symoens J, Veys E, Mielans M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep. 1978;62:1721–30.PubMed
31.
go back to reference Williams GT, Johnson SAN, Dieppe PA, Huskisson EC. Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis. 1978;37:366–9.PubMedCrossRef Williams GT, Johnson SAN, Dieppe PA, Huskisson EC. Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis. 1978;37:366–9.PubMedCrossRef
32.
go back to reference Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88:408–11.PubMedCrossRef Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther. 2010;88:408–11.PubMedCrossRef
33.
go back to reference Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012;50:231–41.CrossRef Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012;50:231–41.CrossRef
34.
go back to reference Chai PR, Bastan W, Machan J, Hack JB, Babu KM. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med. 2011;18:1141–7.PubMedCrossRef Chai PR, Bastan W, Machan J, Hack JB, Babu KM. Levamisole exposure and hematologic indices in cocaine users. Acad Emerg Med. 2011;18:1141–7.PubMedCrossRef
35.
go back to reference •• Poon SH, Baliog Jr CR, Sams RN, et al. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum. 2011;41:434–44. Complete description of clinical and hematological manifestations associated with levamisole-contaminated cocaine use.PubMedCrossRef •• Poon SH, Baliog Jr CR, Sams RN, et al. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum. 2011;41:434–44. Complete description of clinical and hematological manifestations associated with levamisole-contaminated cocaine use.PubMedCrossRef
36.
go back to reference •• Khan TA, Cuchacovich R, Espinoza LR, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011;41:445–54. Comprehensive report with complete literature review of clinical and laboratory manifestations associated with levamisole-contaminated cocaine use.PubMedCrossRef •• Khan TA, Cuchacovich R, Espinoza LR, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisole-contaminated cocaine use. Semin Arthritis Rheum. 2011;41:445–54. Comprehensive report with complete literature review of clinical and laboratory manifestations associated with levamisole-contaminated cocaine use.PubMedCrossRef
37.
go back to reference Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol. 2012;19:27–31.PubMedCrossRef Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol. 2012;19:27–31.PubMedCrossRef
38.
go back to reference Perkisas S, Vrelust I, Martin M, Gadisseur A, Schroyens W. A warning about agranulocytosis with the use of cocaine adulterated with levamisole. Acta Clin Belg. 2011;66:226–7.PubMed Perkisas S, Vrelust I, Martin M, Gadisseur A, Schroyens W. A warning about agranulocytosis with the use of cocaine adulterated with levamisole. Acta Clin Belg. 2011;66:226–7.PubMed
39.
go back to reference Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012;40:1067–75.PubMedCrossRef Wolford A, McDonald TS, Eng H, et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos. 2012;40:1067–75.PubMedCrossRef
40.
go back to reference Ching JA, Smith Jr DJ. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012;33:1–5.CrossRef Ching JA, Smith Jr DJ. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res. 2012;33:1–5.CrossRef
41.
go back to reference Freyer CW, Peters M. Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion. Pharmacotherapy. 2012;32:17–23.CrossRef Freyer CW, Peters M. Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion. Pharmacotherapy. 2012;32:17–23.CrossRef
42.
go back to reference Jacobs RS, Silva CY, Powers JG, et al. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012;34:208–13.CrossRef Jacobs RS, Silva CY, Powers JG, et al. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol. 2012;34:208–13.CrossRef
43.
go back to reference Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011;17:193–6.PubMed Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol. 2011;17:193–6.PubMed
44.
go back to reference Zwang NA, Van Wagner LB, Rose S. A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011;17:197–200.PubMed Zwang NA, Van Wagner LB, Rose S. A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol. 2011;17:197–200.PubMed
45.
go back to reference Farmer RW, Malhotra PS, Mays MP, et al. Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res. 2012;33:e6–11.PubMedCrossRef Farmer RW, Malhotra PS, Mays MP, et al. Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res. 2012;33:e6–11.PubMedCrossRef
46.
go back to reference • Graf J, Lynch K, Yeh CL, et al. Purpura, cutaneous necrosis, and anti-neutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum. 2011;63:3998–4001. Very good description of the dermatological and autoimmune manifestations associated with the use of levamisole-contaminated cocaine.PubMedCrossRef • Graf J, Lynch K, Yeh CL, et al. Purpura, cutaneous necrosis, and anti-neutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum. 2011;63:3998–4001. Very good description of the dermatological and autoimmune manifestations associated with the use of levamisole-contaminated cocaine.PubMedCrossRef
47.
go back to reference McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6:2799–805.PubMedCrossRef McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6:2799–805.PubMedCrossRef
48.
go back to reference Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012;23 [Epub ahead of print]. Gulati S, Donato AA. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012;23 [Epub ahead of print].
49.
go back to reference Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med. 2011;Sep 27 [Epub ahead of print]. Friend K, Milone MC, Perrone J. Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med. 2011;Sep 27 [Epub ahead of print].
50.
go back to reference •• Lee KC, Ladizinski B, Federman DG. Complications associated with the use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87:581–6. Excellent review of the subject.PubMedCrossRef •• Lee KC, Ladizinski B, Federman DG. Complications associated with the use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc. 2012;87:581–6. Excellent review of the subject.PubMedCrossRef
Metadata
Title
Cocaine-Induced Vasculitis: Clinical and Immunological Spectrum
Authors
Luis R. Espinoza
Rodolfo Perez Alamino
Publication date
01-12-2012
Publisher
Current Science Inc.
Published in
Current Rheumatology Reports / Issue 6/2012
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-012-0283-1

Other articles of this Issue 6/2012

Current Rheumatology Reports 6/2012 Go to the issue

RHEUMATIC MANIFESTATIONS OF OTHER DISEASES (R STAUD, SECTION EDITOR)

Control of Arthritis Pain with Anti–Nerve-Growth Factor: Risk and Benefit

RHEUMATIC MANIFESTATIONS OF OTHER DISEASES (R STAUD, SECTION EDITOR)

The Role of the Central Nervous System in Osteoarthritis Pain and Implications for Rehabilitation

VASCULITIS (LR ESPINOZA, SECTION EDITOR)

Advances in Therapy for ANCA-Associated Vasculitis

VASCULITIS (LR ESPINOZA, SECTION EDITOR)

Damage Assessment in ANCA-Associated Vasculitis